Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Shih‐Gang Wang is a leading urologic oncologist whose research focuses on upper tract urothelial carcinoma (UTUC), a particularly prevalent cancer in Taiwan, where it is considered a high endemic area. His major contributions center on evaluating surgical outcomes and refining treatment guidelines for this challenging disease. Notably, his 2024 landmark study, "Segmental ureterectomy outcome of upper tract urothelial carcinoma in a high endemic area: A Taiwan nationwide collaborative study," provides critical evidence supporting segmental ureterectomy as a viable, organ-sparing option for selected patients with mid- and distal ureteral tumors. This work addresses a significant gap in the literature, as Taiwan lacks comprehensive treatment outcome analyses despite its high UTUC burden. With 4 citations already, this paper is gaining traction among clinicians and researchers seeking to optimize surgical decision-making in endemic regions. Dr. Wang’s collaborative nationwide approach underscores his commitment to generating real-world, population-specific data that directly impacts clinical practice. His research not only advances urologic oncology but also offers a model for studying regionally prevalent cancers, making him a key figure in the fight against UTUC in Asia.